跳至主要内容
临床试验/NCT05833009
NCT05833009招募中不适用

Study on the Optimal Scheme of Acupuncture Treatment for Schizophrenia-related Central Obesity

Shanghai Mental Health Center2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
2
主要终点
Change from Baseline Waist Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

研究概览

简要总结

This clinical trial aims to test the effect of acupuncture in patients with schizophrenia-related central obesity. The main question it aims to answer is:

• The effect, safety, and maintenance of acupuncture on schizophrenia-related central obesity.

Participants will receive acupuncture treatment on purpose acupoints, acupuncture on acupoint peripheries, or fake acupuncture treatment on purpose acupoints for 20 weeks. And they need three follow-up visits during the treatment period and two follow-up visits after treatment.

Researchers will compare the waist circumstance of these three groups to see if the purpose acupoints are valid for schizophrenia-related central obesity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders: Fifth Edition);
  • •Continuous use of antipsychotics for more than one year (may be combined with mood stabilizers, antianxiety medications, antidepressants, and benzodiazepines);
  • •Abdominal obesity (central obesity): waist circumference ≥90cm for men or ≥85cm for women (Chinese Standard);
  • •All participants and their guardians signed informed consent.

排除标准

  • •Had various traditional Chinese medicine or chemical drugs, or acupuncture treatments for central obesity within two weeks before enrollment;
  • •Pregnant or lactating woman;
  • •Organic mental disorders and mental disorders induced by psychoactive and non-addictive substances;
  • •With other diseases affecting their mental state (e.g., chronic obstructive pulmonary disease, coronary heart disease, angina pectoris, stroke, painful joint diseases, severe psychiatric diseases, tumors, and other physical diseases)
  • •Severe liver and kidney insufficiency or other serious diseases of the system;
  • •With a family history of metabolic diseases such as hypertension, diabetes, and hyperlipidemia;
  • •Acupuncture dizziness, needle phobia, and other intolerant acupuncture treatment;
  • •Patients who are not treated according to the regulations, cannot determine the efficacy or have incomplete data affecting the efficacy and safety evaluation.

研究组 & 干预措施

Acupuncture Group

Experimental

They receive actual acupuncture on purpose acupoints.

干预措施: Acupuncture (Device)

Sham Group

Sham Comparator

They receive actual acupuncture on points but not an acupoint around the purpose acupoints.

干预措施: Acupuncture (Device)

non-Acupuncture Group

Sham Comparator

They receive fake acupuncture (no needle) on purpose acupoints.

干预措施: Acupuncture (Device)

结局指标

主要结局

Change from Baseline Waist Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

时间窗: Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

Waist Circumference in centimiter

次要结局

  • Change from Baseline Body Weight Index at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks)
  • Change from Baseline Blood Triglyceride at 16 weeks, 32 weeks, respectively(Baseline, 16 weeks, 32 weeks)
  • Change from Baseline Blood Total Cholesterol at 16 weeks, 32 weeks, respectively(Baseline, 16 weeks, 32 weeks)
  • Change from Baseline Clinical Global Impression at 8 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 20 weeks, 32 weeks)
  • Change from Baseline Personal and Social Performance Scale at 8 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 20 weeks, 32 weeks)
  • Change from Baseline Appetite visual analogue scale at 8 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 20 weeks, 32 weeks)
  • Change from Baseline Positive And Negative Syndrome Scale at 8 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 20 weeks, 32 weeks)
  • Change from Baseline Hip Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks)
  • Change from Baseline both Blood Pressure at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks)
  • Change from Baseline Blood Low-density Lipoprotein at 16 weeks, 32 weeks, respectively(Baseline, 16 weeks, 32 weeks)
  • Change from Baseline Blood High-density Lipoprotein at 16 weeks, 32 weeks, respectively(Baseline, 16 weeks, 32 weeks)
  • Change from Baseline Blood Glucose at 16 weeks, 32 weeks, respectively(Baseline, 16 weeks, 32 weeks)
  • Change from Baseline Treatment Emergent Symptom Scale at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively(Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验